Interaction between HLA-G and NK Cell Receptor KIR2DL4 Orchestrates HER2-Positive Breast Cancer Resistance to Trastuzumab

Investigators found that the nonclassical histocompatibility antigen HLA-G desensitized breast cancer cells to trastuzumab by binding to the natural killer cell receptor KIR2DL4.